Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Mesco Pharmaceuticals: Board Meeting Intimation for Board Meeting Intimation For Consider And Approve The Standalone Unaudited Financial Results For The Quarter Ended On 30Th September 2021 Along With Limited Review Reports
News Announcement

Mesco Pharmaceuticals: Board Meeting Intimation for Board Meeting Intimation For Consider And Approve The Standalone Unaudited Financial Results For The Quarter Ended On 30Th September 2021 Along With Limited Review Reports

08-Nov-2021 Follow Value Research Online on Google download pdfDownload PDF Mesco Pharmaceuticals

MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 inter alia to consider and approve The standalone unaudited financial results for the quarter ended on 30th September 2021 along with Limited Review Reports.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan